These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12172340)

  • 21. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J; Aluoja A; Vasar V; Vasar E; Podar T; Bradwejn J
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citalopram in Treatment of Pregnant Women With Panic Disorder: A Retrospective Study.
    Uguz F
    J Clin Psychopharmacol; 2020; 40(6):615-617. PubMed ID: 32991527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients.
    Zhuang X; Xu H; Fang Z; Xu C; Xue C; Hong X
    Eur J Pharmacol; 2018 Sep; 834():213-220. PubMed ID: 30031795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Depressive disorders in panic attack patients and their correction with escitalopram].
    Levada OA; Cherednichenko NV
    Lik Sprava; 2005; (5-6):77-80. PubMed ID: 16396301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptom-network dynamics in irritable bowel syndrome with comorbid panic disorder using electronic momentary assessment: A randomized controlled trial of escitalopram vs. placebo.
    Kreiter D; Drukker M; Mujagic Z; Vork L; Rutten BPF; van Os J; Masclee AAM; Kruimel JW; Leue C
    J Psychosom Res; 2021 Feb; 141():110351. PubMed ID: 33412422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiety sensitivity and modulation of the serotonergic system in patients with PD.
    Romano P; van Beek N; Cucchi M; Biffi S; Perna G
    J Anxiety Disord; 2004; 18(3):423-31. PubMed ID: 15125987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can psychopharmacological treatment change personality traits in patients with panic disorder?
    Kipper L; Wachleski C; Salum GA; Heldt E; Blaya C; Manfro GG
    Braz J Psychiatry; 2009 Dec; 31(4):307-13. PubMed ID: 20098823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personality traits and escitalopram treatment outcome in major depression.
    Aluoja A; Tõru I; Raag M; Eller T; Võhma Ü; Maron E
    Nord J Psychiatry; 2018 Jul; 72(5):354-360. PubMed ID: 29688152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single photon emission computed tomography in posttraumatic stress disorder before and after treatment with a selective serotonin reuptake inhibitor.
    Seedat S; Warwick J; van Heerden B; Hugo C; Zungu-Dirwayi N; Van Kradenburg J; Stein DJ
    J Affect Disord; 2004 May; 80(1):45-53. PubMed ID: 15094257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 34. A double-blind crossover comparison of clomipramine and desipramine in the treatment of panic disorder.
    Sasson Y; Iancu I; Fux M; Taub M; Dannon PN; Zohar J
    Eur Neuropsychopharmacol; 1999 Mar; 9(3):191-6. PubMed ID: 10208287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of personality, measured by the Karolinska Scales of Personality (KSP), on symptoms among subjects in suspected sick buildings.
    Runeson R; Norbäck D; Klinteberg B; Edling C
    Indoor Air; 2004 Dec; 14(6):394-404. PubMed ID: 15500632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment.
    Lopez-Vilchez I; Serra-Millas M; Navarro V; Rosa Hernandez M; Villalta J; Diaz-Ricart M; Gasto C; Escolar G; Galan AM
    J Affect Disord; 2014 Apr; 159():39-45. PubMed ID: 24679387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype.
    Kellner M; Muhtz C; Demiralay C; Husemann J; Koelsch W; Yassouridis A; Wiedemann K
    J Psychiatr Res; 2009 Mar; 43(6):642-8. PubMed ID: 18930474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personality traits in treated Wilson's disease determined by means of the Karolinska Scales of Personality (KSP).
    Portala K; Westermark K; Ekselius L; von Knorring L
    Eur Psychiatry; 2001 Sep; 16(6):362-71. PubMed ID: 11585717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders.
    Aberg-Wistedt A; Hasselmark L; Stain-Malmgren R; Apéria B; Kjellman BF; Mathé AA
    Acta Psychiatr Scand; 1998 May; 97(5):374-80. PubMed ID: 9611088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citalopram as an adjuvant in schizophrenia: further evidence for a serotonergic dimension in schizophrenia.
    Taiminen TJ; Syvälahti E; Saarijärvi S; Niemi H; Lehto H; Ahola V; Salokangas RK
    Int Clin Psychopharmacol; 1997 Jan; 12(1):31-5. PubMed ID: 9179631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.